SenesTech, Inc. develops a technology for managing animal pest populations through fertility control. The company focuses on commercializing ContraPest, a fertility control product for use in controlling rat populations. It is also developing a pipeline of fertility control and animal health products, including plant-based fertility control, feral animal fertility control, non-surgical spay and neutering, boar taint, and animal cancer treatment. The company was founded in 2004 and is headquartered in Flagstaff, Arizona.
Industry, Sector and Symbol
Industry Agricultural chemicals
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:SNES
CUSIPN/A
Phone928-779-4143
Debt
Debt-to-Equity Ratio0.10
Current Ratio5.65
Quick Ratio4.89
Price-To-Earnings
Trailing P/E Ratio-1.63
Forward P/E Ratio-3.64
P/E GrowthN/A
Sales & Book Value
Annual Sales$50,000.00
Price / Sales602.06
Cash FlowN/A
Price / CashN/A
Book Value$0.48 per share
Price / Book3.79
Profitability
EPS (Most Recent Fiscal Year)($1.12)
Net Income$-12,280,000.00
Net Margins-17,962.50%
Return on Equity-205.29%
Return on Assets-151.86%
Miscellaneous
Employees39
Outstanding Shares16,540,000
SenesTech (NASDAQ:SNES) Frequently Asked Questions
What is SenesTech's stock symbol?
SenesTech trades on the NASDAQ under the ticker symbol "SNES."
How were SenesTech's earnings last quarter?
SenesTech Inc (NASDAQ:SNES) issued its earnings results on Monday, May, 14th. The company reported ($0.16) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($0.15) by $0.01. The firm earned $0.02 million during the quarter, compared to analysts' expectations of $0.25 million. SenesTech had a negative net margin of 17,962.50% and a negative return on equity of 205.29%. View SenesTech's Earnings History.
What price target have analysts set for SNES?
2 brokerages have issued 1-year price objectives for SenesTech's shares. Their predictions range from $3.00 to $14.00. On average, they expect SenesTech's stock price to reach $8.50 in the next twelve months. View Analyst Ratings for SenesTech.
Are investors shorting SenesTech?
SenesTech saw a increase in short interest in the month of May. As of May 31st, there was short interest totalling 3,005,577 shares, an increase of 1,088.9% from the May 15th total of 252,800 shares. Based on an average trading volume of 10,015,816 shares, the short-interest ratio is currently 0.3 days. Approximately 22.2% of the company's shares are short sold.
Who are some of SenesTech's key competitors?
Who are SenesTech's key executives?
SenesTech's management team includes the folowing people:
- Dr. Loretta Powers Mayer, Co-Founder, Chair of the Board, CEO & Chief Scientific Officer (Age 69)
- Dr. Cheryl Ann Dyer, Co-Founder, Pres, Chief Research Officer & Director (Age 66)
- Mr. Thomas C. Chesterman, CFO, Exec. VP, Treasurer & Assistant Sec. (Age 59)
- Mr. Joe Malinowski, VP of Sales
- Ms. Kim Wolin, Exec. VP of Operations & Sec. (Age 63)
When did SenesTech IPO?
(SNES) raised $15 million in an IPO on Thursday, December 8th 2016. The company issued 1,900,000 shares at a price of $8.00 per share. Roth Capital Partners acted as the underwriter for the IPO and Craig-Hallum Capital Group was co-manager.
Has SenesTech been receiving favorable news coverage?
Media coverage about SNES stock has been trending somewhat positive on Wednesday, Accern Sentiment Analysis reports. Accern ranks the sentiment of news coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. SenesTech earned a coverage optimism score of 0.22 on Accern's scale. They also assigned news headlines about the company an impact score of 44.90 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the near term.
Who are SenesTech's major shareholders?
SenesTech's stock is owned by a number of of retail and institutional investors. Top institutional investors include Sabby Management LLC (4.80%) and CVI Holdings LLC (3.11%). Company insiders that own SenesTech stock include Andrew Altman, Cheryl Ann Dyer, Grover T Wickersham, Julia Ann Williams, Loretta Powers Mayer, Robert E Ramsey Jr and Thomas C Chesterman. View Institutional Ownership Trends for SenesTech.
Which institutional investors are buying SenesTech stock?
SNES stock was purchased by a variety of institutional investors in the last quarter, including CVI Holdings LLC and Sabby Management LLC. Company insiders that have bought SenesTech stock in the last two years include Andrew Altman, Grover T Wickersham, Julia Ann Williams and Robert E Ramsey Jr. View Insider Buying and Selling for SenesTech.
How do I buy shares of SenesTech?
Shares of SNES can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is SenesTech's stock price today?
One share of SNES stock can currently be purchased for approximately $1.82.
How big of a company is SenesTech?
SenesTech has a market capitalization of $27.78 million and generates $50,000.00 in revenue each year. The company earns $-12,280,000.00 in net income (profit) each year or ($1.12) on an earnings per share basis. SenesTech employs 39 workers across the globe.
How can I contact SenesTech?
SenesTech's mailing address is 3140 NORTH CADEN COURT SUITE 1, FLAGSTAFF AZ, 86004. The company can be reached via phone at 928-779-4143 or via email at [email protected]
MarketBeat Community Rating for SenesTech (SNES)
MarketBeat's community ratings are surveys of what our community members think about SenesTech and other stocks. Vote "Outperform" if you believe SNES will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SNES will underperform the S&P 500 over the long term. You may vote once every thirty days.
